US Drug Recall Register
Class III · Low risk Terminated Initiated May 8, 2023 (3 years ago)

Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscular…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling: Not Elsewhere Classified; A typographical error was observed in the NDC number on the preprinted Individual Folding Cartons (secondary packaging only). Incorrect NDC Number 70121-1573-1; Correct NDC Number 70121-1574-1.

What was recalled

Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscular, Intrasynovial and Soft Tissue Injection Only, Not for Intravenous Use, 1 mL Single Dose Vial, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Parenteral Unit, Ahmedabad 382213, India, Amneal Pharamceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1574-01.

Recalling firm
Amneal Pharmaceuticals of New York, LLC
NDC code
70121-1574-01
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0756-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Methylprednisolone recalls

See all